510 related articles for article (PubMed ID: 26463960)
21. STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke.
Cappellari M; Turcato G; Forlivesi S; Zivelonghi C; Bovi P; Bonetti B; Toni D
Stroke; 2018 Feb; 49(2):397-404. PubMed ID: 29311264
[TBL] [Abstract][Full Text] [Related]
22. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
[TBL] [Abstract][Full Text] [Related]
23. Should statins be paused or discontinued after thrombolysis or acute intracerebral hemorrhage? No!
Scheitz JF; Nolte CH; Endres M
Stroke; 2013 May; 44(5):1472-6. PubMed ID: 23444304
[No Abstract] [Full Text] [Related]
24. Interaction of Recanalization, Intracerebral Hemorrhage, and Cerebral Edema After Intravenous Thrombolysis.
Cheripelli BK; Huang X; MacIsaac R; Muir KW
Stroke; 2016 Jul; 47(7):1761-7. PubMed ID: 27301943
[TBL] [Abstract][Full Text] [Related]
25. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage.
Vandelli L; Marietta M; Gambini M; Cavazzuti M; Trenti T; Cenci MA; Casoni F; Bigliardi G; Pentore R; Nichelli P; Zini A
J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721
[TBL] [Abstract][Full Text] [Related]
26. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.
Mazya M; Egido JA; Ford GA; Lees KR; Mikulik R; Toni D; Wahlgren N; Ahmed N;
Stroke; 2012 Jun; 43(6):1524-31. PubMed ID: 22442178
[TBL] [Abstract][Full Text] [Related]
27. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT).
Yamaguchi T; Mori E; Minematsu K; Nakagawara J; Hashi K; Saito I; Shinohara Y;
Stroke; 2006 Jul; 37(7):1810-5. PubMed ID: 16763187
[TBL] [Abstract][Full Text] [Related]
28. Within-day and weekly variations of thrombolysis in acute ischemic stroke: results from safe implementation of treatments in stroke-international stroke thrombolysis register.
Lorenzano S; Ahmed N; Tatlisumak T; Gomis M; Dávalos A; Mikulik R; Sevcik P; Ollikainen J; Wahlgren N; Toni D;
Stroke; 2014 Jan; 45(1):176-84. PubMed ID: 24262329
[TBL] [Abstract][Full Text] [Related]
29. Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator.
Cocho D; Borrell M; Martí-Fàbregas J; Montaner J; Castellanos M; Bravo Y; Molina-Porcel L; Belvís R; Díaz-Manera JA; Martínez-Domeño A; Martínez-Lage M; Millán M; Fontcuberta J; Martí-Vilalta JL
Stroke; 2006 Apr; 37(4):996-9. PubMed ID: 16497981
[TBL] [Abstract][Full Text] [Related]
30. Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients.
Li W; Lin L; Zhang M; Wu Y; Liu C; Li X; Huang S; Liang C; Wang Y; Chen J; Feng W
Stroke; 2016 Oct; 47(10):2649-51. PubMed ID: 27608821
[TBL] [Abstract][Full Text] [Related]
31. Time to recanalization and risk of symptomatic intracerebral haemorrhage in patients treated with intravenous thrombolysis.
Dorado L; Millán M; Pérez de la Ossa N; Guerrero C; Gomis M; Aleu A; López-Cancio E; Cuadras P; Dávalos A
Eur J Neurol; 2012 Sep; 19(9):1251-5. PubMed ID: 22568604
[TBL] [Abstract][Full Text] [Related]
32. Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.
Anderson CS; Robinson T; Lindley RI; Arima H; Lavados PM; Lee TH; Broderick JP; Chen X; Chen G; Sharma VK; Kim JS; Thang NH; Cao Y; Parsons MW; Levi C; Huang Y; Olavarría VV; Demchuk AM; Bath PM; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Ricci S; Roffe C; Pandian J; Billot L; Woodward M; Li Q; Wang X; Wang J; Chalmers J;
N Engl J Med; 2016 Jun; 374(24):2313-23. PubMed ID: 27161018
[TBL] [Abstract][Full Text] [Related]
33. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
Aoki S; Hosomi N; Sueda Y; Kono T; Takamatsu K; Ohyama H; Torii T; Kitamura T; Nomura E; Noda K; Ohtsuki T; Matsumoto M;
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972
[TBL] [Abstract][Full Text] [Related]
34. Community-based thrombolytic therapy of acute ischemic stroke in Helsinki.
Lindsberg PJ; Soinne L; Roine RO; Salonen O; Tatlisumak T; Kallela M; Häppölä O; Tiainen M; Haapaniemi E; Kuisma M; Kaste M
Stroke; 2003 Jun; 34(6):1443-9. PubMed ID: 12738891
[TBL] [Abstract][Full Text] [Related]
35. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
[TBL] [Abstract][Full Text] [Related]
36. Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke.
Tsivgoulis G; Kadlecová P; Kobayashi A; Czlonkowska A; Brozman M; Švigelj V; Csiba L; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Katsanos AH; Rudolf J; Krespi Y; Mikulik R
Stroke; 2015 Sep; 46(9):2681-4. PubMed ID: 26173726
[TBL] [Abstract][Full Text] [Related]
37. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials.
Martí-Fàbregas J; Bravo Y; Cocho D; Martí-Vilalta JL; Díaz-Manera J; San Román L; Puig M; Blanco M; Castellanos M; Millán M; Roquer J; Obach V; Maestre J
Cerebrovasc Dis; 2007; 23(2-3):85-90. PubMed ID: 17114877
[TBL] [Abstract][Full Text] [Related]
38. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N;
Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853
[TBL] [Abstract][Full Text] [Related]
39. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset.
Diedler J; Ahmed N; Sykora M; Uyttenboogaart M; Overgaard K; Luijckx GJ; Soinne L; Ford GA; Lees KR; Wahlgren N; Ringleb P
Stroke; 2010 Feb; 41(2):288-94. PubMed ID: 20056933
[TBL] [Abstract][Full Text] [Related]
40. Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies.
Külkens S; Hacke W
Expert Rev Neurother; 2007 Jul; 7(7):783-8. PubMed ID: 17610385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
